E-drug: Amodiaquine in the USP-NF
-------------------------------------------------------------------------
I have just been informed that USP is considering dropping the monograph on
amodiaquine from the U.S. Pharmacopeia. I have explained to people making
this decision that amodiaquine is still in use, especially in Africa,
although it is not on WHO's EDL. Would any e-drugs participants like to
offer an opinion on the value of retaining a monograph (and reference
standards materials) for this drug? I would appreciate hearing from you.
Sincerely,
Nancy Blum, M.P.H., M.A.
Program Director,
Global Assistance Initiatives
U.S.Pharmacopeia
12601 Twinbrook Parkway
Rockville, MD 20852
NLB@usp.org
(301) 816-8161
(301) 816-8374 FAX
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html